Differential requirement of the epidermal growth factor receptor for G protein-mediated activation of transcription factors by lysophosphatidic acid

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Oyesanya, Regina A ^a   Greenbaum, Susie ^a   Dang, David ^a   Lee, Zendra ^a   Mukherjee, Abir ^a   Wu, Jinhua ^a   Dent, Paul ^a   Fang, Xianjun ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSOPHOSPHATIDIC ACID; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR AP 1; EPIDERMAL GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 8; LYSOPHOSPHOLIPID; PHOSPHOTYROSINE;

ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GENE FUNCTION; HUMAN; HUMAN CELL; OVARY CANCER; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; BIOSYNTHESIS; CANCER INVASION; CELL MOTION; DRUG EFFECT; FEMALE; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; FEMALE; GTP-BINDING PROTEINS; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-8; LYSOPHOSPHOLIPIDS; NEOPLASM INVASIVENESS; NF-KAPPA B; PHOSPHOTYROSINE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSCRIPTION FACTOR AP-1;

EID: 76749161880     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-8     Document Type: Article

References (38)

1. Smyth SS, Cheng HY, Miriyala S, Panchatcharam M, Morris AJ. Roles of lysophosphatidic acid in cardiovascular physiology and disease. Biochim Biophys Acta 2008, 1781:563-570. 2572771, 18586114.
2. Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 1993, 291:677-680. 1132420, 8489494.
3. Aoki J, Inoue A, Okudaira S. Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 2008, 1781:513-518.
4. Noguchi K, Herr D, Mutoh T, Chun J. Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 2009, 9:15-23. 10.1016/j.coph.2008.11.010, 19119080.
5. Hecht JH, Weiner JA, Post SR, Chun J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J Cell Biol 1996, 135:1071-1083. 10.1083/jcb.135.4.1071, 2133395, 8922387.
6. Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, Murakami-Murofushi K, Tsujimoto M, Arai H, Inoue K. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem 1999, 274:27776-27785. 10.1074/jbc.274.39.27776, 10488122.
7. An S, Bleu T, Hallmark OG, Goetzl EJ. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J Biol Chem 1998, 273:7906-7910. 10.1074/jbc.273.14.7906, 9525886.
8. Noguchi K, Ishii S, Shimizu T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 2003, 278:25600-25606. 10.1074/jbc.M302648200, 12724320.
9. Lee CW, Rivera R, Gardell S, Dubin AE, Chun J. GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J Biol Chem 2006, 281:23589-23597. 10.1074/jbc.M603670200, 16774927.
10. Pasternack SM, von Kügelgen I, Aboud KA, Lee YA, Rüschendorf F, Voss K, Hillmer AM, Molderings GJ, Franz T, Ramirez A, Nürnberg P, Nöthen MM, Betz RC. G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat Genet 2008, 40:329-334. 10.1038/ng.84, 18297070.
11. Yanagida K, Masago K, Nakanishi H, Kihara Y, Hamano F, Tajima Y, Taguchi R, Shimizu T, Ishii S. Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6. J Biol Chem 2009, 284:17731-17741. 10.1074/jbc.M808506200, 19386608.
12. Mills GB, Moolenaar WH. The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 2003, 3:582-591. 10.1038/nrc1143, 12894246.
13. Pustilnik TB, Estrella V, Wiener JR, Mao M, Eder A, Watt MA, Bast RC, Mills GB. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin Cancer Res 1999, 5:3704-3710.
14. Hu YL, Tee MK, Goetzl EJ, Auersperg N, Mills GB, Ferrara N, Jaffe RB. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J Natl Cancer Inst 2001, 93:762-768. 10.1093/jnci/93.10.762, 11353786.
15. Fang X, Yu S, Bast RC, Liu S, Xu HJ, Hu SX, LaPushin R, Claret FX, Aggarwal BB, Lu Y, Mills GB. Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells. J Biol Chem 2004, 279:9653-9661. 10.1074/jbc.M306662200, 14670967.
16. Muehlich S, Schneider N, Hinkmann F, Garlichs CD, Goppelt-Struebe M. Induction of connective tissue growth factor (CTGF) in human endothelial cells by lysophosphatidic acid, sphingosine-1-phosphate, and platelets. Atherosclerosis 2004, 175:261-268. 10.1016/j.atherosclerosis.2004.04.011, 15262182.
17. Lee Z, Swaby RF, Liang Y, Yu S, Liu S, Lu K, Bast RC, Mills GB, Fang X. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer. Cancer Res 2006, 66:2740-2748. 10.1158/0008-5472.CAN-05-2947, 16510595.
18. Symowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG, Stack MS. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res 2005, 65:2234-2242. 10.1158/0008.5472.CAN-04-2781, 15781636.
19. Oyesanya R, Lee Z, Wu J, Chen J, Song Y, Dent P, Kordula T, Zhou H, Fang X. Transcriptional and post-transcriptional mechanisms for cyclooxygenase 2 expression induced by lysophosphatidic acid in ovarian cancer cells. FASEB J 2008, 22:2639-2651. 10.1096/fj.07-101428, 2493458, 18362203.
20. Song Y, Wu J, Oyesanya R, Lee Z, Mukherjee A, Fang X. Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a HIF-1-independent mechanism. Clin Cancer Res 2009, 15:492-501. 10.1158/1078-0432.CCR-08-1945, 19147754.
21. Daub H, Wallasch C, Lankenau A, Herrlich A, Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J 1997, 16:7032-7044. 10.1093/emboj/16.23.7032, 1170306, 9384582.
22. Wu J, Cunnick JM. Trans-regulation of epidermal growth factor receptor by lysophosphatidic acid and G protein-coupled receptors. Biochim Biophys Acta 2002, 1582:100-106.
23. Shida D, Fang X, Kordula T, Takabe K, Lepine S, Alvarez SE, Milstien S, Spiegel S. Crosstalk between LPA1 and EGF receptors mediates upregulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. Cancer Res 2008, 68:6569-6577. 10.1158/0008-5472.CAN-08-0411, 2763580, 18701480.
24. Qiao L, Studer E, Leach K, Mckinstry R, Gupta S, Decker R, Kukreja R, Valerie K, Nagarkatti P, El Deiry W, Molkentin J, Schmidt-Ullrich R, Fisher PB, Grant S, Hylemon PB, Dent P. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. Mol Biol Cell 2001, 2:2629-2645.
25. Stanners J, Kabouridis PS, McGuire KL, Tsoukas CD. Interaction between G proteins and tyrosine kinases upon T cell receptor: CD3-mediated signaling. J Biol Chem 1995, 270:30635-30642. 10.1074/jbc.270.8.3602, 8530500.
26. Soede RD, Wijnands YM, Kamp M, Valk MA, Roos E. Gi and Gq/11 proteins are involved in dissemination of myeloid leukemia cells to the liver and spleen whereas bone marrow colonization involves Gq/11 but not Gi. Blood 2000, 96:691-698.
27. Taylor SJ, Shalloway D. Cell cycle-dependent activation of Ras. Curr Biol 1996, 6:1621-1627. 10.1016/S0960-9822(02)70785-9, 8994826.
28. Ren XD, Schwartz MA. Determination of GTP loading on Rho. Methods Enzymol 2000, 325:264-272. full_text, 11036609.
29. Lee Z, Cheng CT, Zhang H, Subler MA, Wu J, Mukherjee A, Windle JJ, Chen CK, Fang X. Role of LPA4/p2y9/GPR23 in negative regulation of cell motility. Mol Biol Cell 2008, 19:5435-5445. 10.1091/mbc.E08-03-0316, 2592656, 18843048.
30. Fang X, Schummer M, Mao M, Yu S, Tabassam FH, Swaby R, Hasegawa Y, Tanyi JL, LaPushin R, Eder A, Jaffe R, Erickson J, Mills GB. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim Biophys Acta 2002, 1582:257-264.
31. Osherov N, Levitzki A. Epidermal-growth-factor-dependent activation of the src-family kinases. Eur J Biochem 1994, 225:1047-1053. 10.1111/j.1432-1033.1994.1047b.x, 7525285.
32. Smith RJ, Sam LM, Justen JM, Bundy GL, Bala GA, Bleasdale JE. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J Pharmacolol Exp Ther 1990, 253:688-697.
33. Marinissen MJ, Chiariello M, Tanos T, Bernard O, Narumiya S, Gutkind JS. The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. Mol Cell 2004, 13:29-41.
34. Chiu TT, Leung WY, Moyer MP, Strieter RM, Rozengurt E. Protein kinase D2 mediates lysophosphatidic acid-induced interleukin 8 production in nontransformed human colonic epithelial cells through NF-kappaB. Am J Physiol Cell Physiol 2007, 292:C767-C777. 10.1152/ajpcell.00308.2006, 16928771.
35. Van Leeuwen FN, Olivo C, Grivell S, Giepmans BN, Collard JG, Moolenaar WH. Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1. J Biol Chem 2003, 278:400-406. 10.1074/jbc.M210151200, 12393875.
36. Rubio I, Rennert K, Wittig U, Wetzker R. Ras activation in response to lysophosphatidic acid requires a permissive input from the epidermal growth factor receptor. Biochem J 2003, 376:571-576. 10.1042/BJ20031410, 1223827, 14580235.
37. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006, 366:2-16. 10.1016/j.gene.2005.10.018, 16377102.
38. Lafky JM, Wilken JA, Baron AT, Maihle NJ. Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim Biophys Acta 2008, 1785:232-265.